How Incyte Corporation stacks up

INCY · against 454 other Healthcare companies listed in US-listed

Growth

82/ 100

Above the middle of the pack.

Ranked #131 of 455 · scores higher than 70% of peers

Bars: peers in each 10-point band of the growth score

66 peers with a growth score of 80–89, including INCY · Click a bar to see the companies

Why growth scores 82?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.

faster revenue growth over three years: stronger than 79% of peers. 3-year revenue growth: 18.3% vs peer median 5.8%
faster growth in earnings per share: stronger than 83% of peers. Earnings per share growth: 78.4% vs peer median 9.8%
faster revenue growth over the last year: stronger than 84% of peers. Revenue growth: 26.9% vs peer median 6.1%

Metric by metric

Position: dot = INCY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	INCY	Peer median	Better than	Weight
Revenue growthHigher is better · 475 reported	26.9%	11.0%	73%	33%
Earnings per share growthHigher is better · 171 reported	78.4%	21.2%	76%	33%
3-year revenue growthHigher is better · 433 reported	18.3%	11.0%	63%	33%

Ranking by growth score

Top 5 and the companies ranked around INCY

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
131	BrightSpring Health Services, Inc.BTSGU · US-listed	Unavailable	82	49
131	Guardant Health, Inc.GH · US-listed	23.5B USD	82	27
131	GRAIL, Inc.GRAL · US-listed	6.2B USD	82	44
131	Hims & Hers Health, Inc.HIMS · US-listed	6.0B USD	82	30
131	Incyte CorporationINCY · US-listed	23.8B USD	82	84
131	LivaNova PLCLIVN · US-listed	4.4B USD	82	66
131	Warby Parker Inc.WRBY · US-listed	2.7B USD	82	44
138	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	81	73
138	Lexicon Pharmaceuticals, Inc.LXRX · US-listed	650M USD	81	48

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…